X4 Pharmaceuticals Inc. (XFOR)
NASDAQ: XFOR
· Real-Time Price · USD
2.71
-0.43 (-13.69%)
At close: Aug 15, 2025, 1:09 PM
-13.69% (1D)
| Bid | 2.71 |
| Market Cap | 30.92M |
| Revenue (ttm) | 31.36M |
| Net Income (ttm) | 14.6M |
| EPS (ttm) | -15.14 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | -0.17 |
| Analyst | Buy |
| Ask | 2.73 |
| Volume | 1,247,310 |
| Avg. Volume (20D) | 3,778,622 |
| Open | 2.89 |
| Previous Close | 3.14 |
| Day's Range | 2.71 - 3.11 |
| 52-Week Range | 1.35 - 26.82 |
| Beta | 0.60 |
About XFOR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XFOR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XFOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
X4 Pharmaceuticals has released their quartely earnings
on Aug 8, 2025:
Next Earnings Release
X4 Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+81.69%
X4 Pharmaceuticals shares are trading higher. The ...
Unlock content with
Pro Subscription
3 months ago
-12.99%
X4 Pharmaceuticals shares are trading lower. The company reported Q1 financial results.
